Figure 4. Response to tetanus toxoid vaccination in kidney-transplant recipients.
(A) Concentration of anti-tetanus toxoid before (white bars) and at 1 month after vaccination (gray bars) in patients who responded to tetanus toxoid vaccination.
(B) Concentration of anti-tetanus toxoid, -DT, -PCP, and -Hib antibodies as measured by ELISA in the 2 patient groups before (white bars) and at 1 month after vaccination (gray bars).